UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in APLS — Apellis Pharmaceuticals, Inc.
CIK 861177
NEW YORK, NY
Position in APLS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
179,953
+0.6% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in APLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in APLS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 179,953 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | — | 178,888 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | — | 167,464 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | — | 301,939 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | — | 222,634 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | — | 212,887 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | — | 191,065 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | — | 208,184 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | — | 139,325 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | — | 141,768 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | — | 145,946 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | — | 99,804 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | — | 99,804 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | — | 75,086 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | — | 69,158 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | — | 351,624 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | — | 390,140 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | — | 373,674 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | — | 203,990 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | — | 212,515 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | — | 56,259 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | — | 64,947 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | — | 66,855 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | — | 65,424 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | — | 47,041 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||